Journal article · 2017 · Open access

From in vivo to in vitro: The medical device testing paradigm shift

Dayna Myers, Alan M Goldberg, Albrecht Poth, Michael F Wolf, Joseph Carraway, James McKim, Kelly P Coleman, Richard Hutchinson, Ronald Brown, Harald F Krug, Anthony Bahinski, Thomas Hartung

ALTEX, 34(4), 479–500 · Published 1 January 2017 · DOI 10.14573/altex.1608081

Free PDFView at the publisherCite this paper

In brief

“From in vivo to in vitro: The medical device testing paradigm shift” is a 2017 journal article by Dayna Myers and 11 co-authors, published in ALTEX. OpenAlex counts 68 citations as of 15 November 2026, which puts it in the top 5% of works published in 2017 by citations. It is open access under a CC BY licence: the full text is free to read at ALTEX.

Citations
68
Most cited in
2025 (12)
Field-weighted impact
8.66
References
75
Authors
12

Abstract

Amid growing efforts to advance the replacement, reduction, and refinement of the use of animals in research, there is a growing recognition that in vitro testing of medical devices can be more effective, both in terms of cost and time, and also more reliable than in vivo testing. Although the technological landscape has evolved rapidly in support of these concepts, regulatory acceptance of alternative testing methods has not kept pace. Despite the acceptance by regulators of some in vitro tests (cytotoxicity, gene toxicity, and some hemocompatibility assays), many toxicity tests still rely on animals (irritation, sensitization, acute toxicity, reproductive/developmental toxicity), even where other industrial sectors have already abandoned them. Bringing about change will require a paradigm shift in current approaches to testing - and a concerted effort to generate better data on risks to human health from exposure to leachable chemicals from medical devices, and to boost confidence in the use of alternative methods to test devices. To help advance these ideas, stir debate about best practices, and coalesce around a roadmap forward, the JHU-Center for Alternatives to Animal Testing (CAAT) hosted a symposium believed to be the first gathering dedicated to the topic of in vitro testing of medical devices. Industry representatives, academics, and regulators in attendance presented evidence to support the unique strengths and challenges associated with the approaches currently in use as well as new methods under development, and drew next steps to push the field forward from their presentations and discussion.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Myers, D., Goldberg, A. M., Poth, A., Wolf, M. F., Carraway, J., McKim, J., Coleman, K. P., Hutchinson, R., Brown, R., Krug, H. F., Bahinski, A., & Hartung, T. (2017). From in vivo to in vitro: The medical device testing paradigm shift. ALTEX, 34(4), 479–500. https://doi.org/10.14573/altex.1608081

MLA 9

Myers, Dayna, et al. “From in vivo to in vitro: The medical device testing paradigm shift.” ALTEX, vol. 34, no. 4, 2017, pp. 479–500. https://doi.org/10.14573/altex.1608081.

Chicago

Myers, Dayna, Alan M Goldberg, Albrecht Poth, Michael F Wolf, Joseph Carraway, James McKim, Kelly P Coleman, et al. 2017. “From in vivo to in vitro: The medical device testing paradigm shift.” ALTEX 34 (4): 479–500. https://doi.org/10.14573/altex.1608081.

Harvard

Myers, D. et al. (2017) ‘From in vivo to in vitro: The medical device testing paradigm shift’, ALTEX, 34(4), pp. 479–500. doi:10.14573/altex.1608081.

IEEE

D. Myers et al., “From in vivo to in vitro: The medical device testing paradigm shift,” ALTEX, vol. 34, no. 4, pp. 479–500, 2017, doi: 10.14573/altex.1608081.

BibTeX

@article{myers2017from,
  title     = {{From in vivo to in vitro: The medical device testing paradigm shift}},
  author    = {Myers, Dayna and Goldberg, Alan M and Poth, Albrecht and Wolf, Michael F and Carraway, Joseph and McKim, James and Coleman, Kelly P and Hutchinson, Richard and Brown, Ronald and Krug, Harald F and Bahinski, Anthony and Hartung, Thomas},
  journal   = {ALTEX},
  year      = {2017},
  volume    = {34},
  number    = {4},
  pages     = {479--500},
  doi       = {10.14573/altex.1608081},
  url       = {https://doi.org/10.14573/altex.1608081}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201844
201955
202099
202199
202299
20231111
202477
20251212
202622

Its field-weighted citation impact is 8.66: it has been cited 8.66 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Veterinary › Small Animals › Animal testing and alternatives

  • alternatives to animal testing
  • 3Rs
  • cytotoxicity
  • hemocompatibility
  • acute toxicity
  • reproductive and developmental toxicity

Work with this paper

Most-cited papers in Veterinary

All highly cited Veterinary papers

Questions about this paper

How do I cite this paper in APA style?

Myers, D., Goldberg, A. M., Poth, A., Wolf, M. F., Carraway, J., McKim, J., Coleman, K. P., Hutchinson, R., Brown, R., Krug, H. F., Bahinski, A., & Hartung, T. (2017). From in vivo to in vitro: The medical device testing paradigm shift. ALTEX, 34(4), 479–500. https://doi.org/10.14573/altex.1608081

How many times has this paper been cited?

68 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at ALTEX.

Who wrote this paper?

Dayna Myers, Alan M Goldberg, Albrecht Poth, Michael F Wolf, Joseph Carraway, James McKim, Kelly P Coleman, Richard Hutchinson, Ronald Brown, Harald F Krug, Anthony Bahinski, Thomas Hartung.

What is the DOI of this paper?

10.14573/altex.1608081. The permanent link is https://doi.org/10.14573/altex.1608081.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.